drugset / Trial / NCT02795065

Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients

NCT02795065

Completed 100 enrolled Mohamed Sayed Mohamed Abbas
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare two types of low-molecular-weight heparin, enoxaparin and bemiparin, as regards their efficacy and safety in venous thromboembolism prevention among intensive care unit patients.

Timeline

Start
2014-03
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bemiparin Other / unclassified 3500 iu Subcutaneous
Comparator Enoxaparin sodium Other / unclassified 40 mg Subcutaneous